Although the increased galectin-3 is not specific for RA, the serum levels of galectin-3 were significantly associated with the C-reactive protein (CRP) levels and the disease activity scores in patients with JIA, suggesting that galectin-3 may be utilized as a biomarker for the disease progression of JIA [98]. This evidence concerns the gene LGALS3 and rheumatoid arthritis.